首页> 外国专利> Powder formulation containing antagonist CGRP (1 - N2 - (3,5 - Bromine - N - ((4 - (3,4-dihydro - 2 (1H) - oxoquinazolin - 3 - yl) - piperidinyl) - carbonyl) - D - L lysyl tyrosyl) - 4 - (4) - - piridinil) - piperazine, Process for their Preparation and their use as inhaled

Powder formulation containing antagonist CGRP (1 - N2 - (3,5 - Bromine - N - ((4 - (3,4-dihydro - 2 (1H) - oxoquinazolin - 3 - yl) - piperidinyl) - carbonyl) - D - L lysyl tyrosyl) - 4 - (4) - - piridinil) - piperazine, Process for their Preparation and their use as inhaled

机译:包含拮抗剂CGRP(1-N2-(3,5-溴-N-((4-(3,4-二氢-2(1H)-氧代喹唑啉-3-基)-哌啶基)-哌啶基)-羰基)-羰基)-D- L-赖氨酰酪氨酰)-4-(4)--吡地尼)-哌嗪,其制备方法和吸入用途

摘要

The invention is reduced to a lung or nasal aspirated powder, which includes a surface particle in the form of CGRP 1 - (N2 - (3,5-dibromo-n - ((4 - (3,4-dibromo-n -) (4 - (3,4-dibromo-n -) (oxoquinazolin-3-il) - 1-piperidinil) - carbonil - (d-thyroid) - L-lysine) - 4 - (4-pyridine) - piperazina (a), SC (50t) under standard conditions, Relative humidity 75%,The inanimate state of these particles, the preparation procedure, and the procedure used to make inhaled powder for headache treatment, migrators, and cluster headaches remain stable.
机译:本发明简化为肺或鼻抽吸粉末,其包括呈CGRP 1-(N 2-(3,5-二溴-n-((4--3,4-二溴-n-) (4-(3,4-二溴-n-)(氧代喹唑啉-3-il)-1-哌啶子)-羰基-(d-甲状腺)-L-赖氨酸)-4-(4-吡啶)-哌嗪嗪(a ),SC(50t)在标准条件下,相对湿度75%下,这些颗粒的无生命状态,制备过程以及用于制备用于治疗头痛,移民和丛集性头痛的吸入性粉剂的过程保持稳定。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号